AKT1 and tongue cancer: We previously reported that ezrin contributes to the development of tongue cancer, suggesting its usefulness as a novel therapeutic target.4 To screen for additional treatment targets, we first evaluated the possible contributions of extracellular signal-related kinase (ERK) and AKT to the development of tongue cancer by immunohistochemical analyses.